Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

RENAGEL

SEVELAMER HYDROCHLORIDE

Standard Dose
403MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview RENAGEL is listed in Drugs@FDA under application 020926 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SEVELAMER HYDROCHLORIDE Form and strength CAPSULE;ORAL - 403MG Sponsor GENZYME Submission history Latest submission status date: 2004-02-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview RENAGEL is listed in Drugs@FDA under application 020926 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SEVELAMER HYDROCHLORIDE Form and strength CAPSULE;ORAL - 403MG Sponsor GENZYME Submission history Latest submission status date: 2004-02-06 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
RENAGEL (SEVELAMER HYDROCHLORIDE) | Drug Monograph | MedicHelpline